Table 2. Pharmacokinetic parameters of DTZ in rats of groups A, B and C.
Parameter | Group A | Group B | Group C |
---|---|---|---|
Cmax (ng/mL) | 220.08 ± 10.2 | 203.81 ± 12.07 | 244.66 ± 3.75 |
Tmax (h) | 0.50 ± 0.08 | 1.00 ± 0 | 1.00 ± 0 |
MRT (h) | 4.60 ± 0.57 | 4.54 ± 0.31 | 2.22 ± 0.07 |
Half Life (h) | 3.06 ± 0.40 | 2.81 ± 0.21 | 1.46 ± 0.08 |
AUC 0–6h (ng.h.mL−1) | 615.46 ± 38.25 | 642.14 ± 32.22 | 518.29 ± 6.37 |
AUC 0–∞ (ng.h.mL−1) | 862.26 ± 95.42 | 876.41 ± 27.59 | 550.06 ± 6.87 |
AUMC 0–6h (ng.h2.mL−1) | 1490 ± 38.25 | 1569.79 ± 32.22 | 1034.69 ± 6.37 |
AUMC 0–∞ (ng.h2.mL−1) | 4229.71 ± 864.02 | 3989.15 ± 313.58 | 1334.45 ± 97.86 |
Ke (h−1) | 0.25 ± 0.04 | 0.25 ± 0.02 | 0.48 ± 0.02 |
Cmax/AUC 0–∞ (h−1) | 0.28 ± 0.04 | 0.23 ± 0.012 | 0.45 ± 0.01 |